<DOC>
	<DOCNO>NCT01674361</DOCNO>
	<brief_summary>This multi-center , randomize , double-blind , parallel-group , placebo-controlled study evaluate efficacy safety bitopertin ( RO4917838 ) combination selective serotonin reuptake inhibitor ( SSRI ) patient obsessive-compulsive disorder . Patients randomize receive either bitopertin 30 mg bitopertin 10 mg placebo orally daily addition background therapy SSRI . Anticipated time study treatment 16 week .</brief_summary>
	<brief_title>A Study Bitopertin ( RO4917838 ) Combination With Selective Serotonin Reuptake Inhibitors Patients With Obsessive-Compulsive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Adult patient , 18 65 year age Primary diagnosis obsessivecompulsive disorder ( OCD ) per Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) On stable dose selective serotonin reuptake inhibitor ( SSRI ) least 8 week prior screen screen Day 1 An insufficient response current treatment SSRI give adequate dose least 12 week prior Day 1 Females postmenopausal surgically sterile must agree use two adequate method contraception define protocol start screen 90 day last dose study drug Primary OCD symptom hoard More two unsatisfactory trial within last 2 year different serotonin reuptake inhibitor ( include current treatment SSRI ) give adequate dose least 12 week Failure one augmentation therapy one augmentation therapy use conjunction SSRI Recently initiate ( within last 6 month ) current behavioral therapy ( cognitive behavioral therapy exposure response prevention therapy ) Any primary DSMIVTR Axis I disorder OCD Current prior history bipolar disorder , schizophrenia psychotic disorder , schizoaffective disorder , autism autistic spectrum disorder , borderline personality disorder , Gilles de la Tourette syndrome Any eat disorder within last 6 month History od substance dependence and/or substance abuse last 6 month , exception nicotine Previous treatment bitopertin another GlyT1 inhibitor Positive urine drug screen cannabis , amphetamine ( include MDMA/ecstasy ) , cocaine , barbiturate , and/or opiate Prior current general medical condition may impair cognition neuropsychiatric function Body mass index &lt; 18.5 kg/m2 &gt; 40 kg/m2 Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>